Neurocrine Biosciences, Inc. v. Lupin Limited et al > Documents

Date Field	Doc. No.	Description (Pages)
Nov 14, 2023	281	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 11/14/2023) (0)
Nov 13, 2023	279	SO ORDERED re (22 in 1:21-cv-01408-MN, 277 in 1:21-cv-01042-MN, 16 in 1:22-cv-00639-MN, 16 in 1:22-cv-01061-MN) Stipulated Dismissal. Signed by Judge Maryellen Noreika on 11/13/2023. (dlw) (Entered: 11/13/2023) (2)
Nov 13, 2023	280	SO ORDERED re (25 in 1:22-cv-00439-MN, 19 in 1:23-cv-00266-MN, 31 in 1:21-cv-01553-MN, 19 in 1:22-cv-01291-MN, 35 in 1:21-cv-01118-MN, 278 in 1:21-cv-01042-MN) Stipulated Dismissal ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 11/13/2023. (dlw) (Entered: 11/13/2023) (2)
Nov 10, 2023	277	STIPULATION of Dismissal Without Prejudice (as to Lupin Limited, and Lupin Pharmaceuticals, Inc.) by Neurocrine Biosciences, Inc. (Mayo, Andrew) Modified on 11/13/2023 (dlw). (Entered: 11/10/2023) (2)
Nov 10, 2023	278	STIPULATION of Dismissal by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Phillips, John) (Entered: 11/10/2023) (2)
Nov 9, 2023	276	SO ORDERED re (14 in 1:22-cv-00639-MN) (275 in 1:21-cv-01042-MN) (14 in 1:22-cv-01061-MN) (20 in 1:21-cv-01408-MN) Stipulation and Order Dismissing Without Prejudice Defendants Lupin, Inc. and Lupin Atlantis Holdings, S.A. and Amending Caption in the Action to Reflect Same. Party Lupin Atlantis Holdings S.A. and Lupin Inc. terminated. Attorney Jillian M. Schurr; James Michael Lennon and Jitendra M. Malik terminated as to these defendants. Signed by Judge Maryellen Noreika on 11/9/2023. (dlw) (Entered: 11/09/2023) (3)
Nov 8, 2023	275	STIPULATION Dismissing Without Prejudice Defendants Lupin, Inc. and Lupin Atlantic Holdings, S.A. and Amending Caption to Reflect Same by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James) Modified on 11/9/2023 (dlw). (Entered: 11/08/2023) (3)
Nov 6, 2023	274	NOTICE to Take Deposition of S. Craig Dyar, Ph.D. on November 8, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 11/06/2023) (2)
Oct 31, 2023	268	NOTICE to Take Deposition of Stuart Isaacson, M.D., F.A.A.N. on November 16, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 31, 2023	269	NOTICE to Take Deposition of John S. Markowitz, Pharm. D. on November 8, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 31, 2023	270	NOTICE to Take Deposition of Jarkko Rautio, Ph.D. on November 1, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 31, 2023	271	NOTICE to Take Deposition of John J. Koleng, Jr., Ph.D. on November 3, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 31, 2023	272	NOTICE to Take Deposition of Christoph U. Correll, M.D. on November 21, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 31, 2023	273	NOTICE to Take Deposition of John C. Jarosz on November 16, 2023 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 10/31/2023) (2)
Oct 30, 2023	267	MOTION for Pro Hac Vice Appearance of Attorney Leah M. Brackensick - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Certification of Leah M. Brackensick)(Bilson, David) (Entered: 10/30/2023) (0)
Oct 26, 2023	261	NOTICE to Take Deposition of David J. Greenblatt, M.D. on November 1, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 26, 2023	262	NOTICE to Take Deposition of Pardeep K. Gupta, Ph.D. on November 3, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 26, 2023	263	NOTICE to Take Deposition of Ivan T. Hofmann on November 1, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 26, 2023	264	NOTICE to Take Deposition of Anthony J. Rothschild, M.D. on November 6, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 26, 2023	265	NOTICE to Take Deposition of Alan F. Parr, Ph.D. on November 9, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 26, 2023	266	NOTICE to Take Deposition of Jonathan W. Steed, Ph.D. on October 29, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/26/2023) (2)
Oct 25, 2023	260	MOTION for Pro Hac Vice Appearance of Attorney Kathryn R. Judson and Emma N. Ng - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 10/25/2023) (4)
Oct 23, 2023	258	NOTICE OF SERVICE of Reply Expert Reports of Christoph U. Correll, M.D., Stuart H. Isaacson, M.D., F.A.A.N., John C. Jarosz, John J. Koleng, Jr., Ph.D, John S. Markowitz, Pharm. D., Simon Ward, Ph.D. And Stephen R. Byrn, Ph.D. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/23/2023) (2)
Oct 23, 2023	259	NOTICE OF SERVICE of Reply Expert Reports of Christoph U. Correll, M.D., Stuart H. Isaacson, M.D., F.A.A.N., John C. Jarosz, John J. Koleng, Jr., Ph.D., John S. Markowitz, Pharm. D. And Simon Ward, Ph.D. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/23/2023) (2)
Oct 20, 2023	257	NOTICE to Take Deposition of William C. Schinzer, Ph.D. on October 24, 2023 filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/20/2023) (2)
Oct 19, 2023	256	NOTICE OF SERVICE of (1) Reply Expert Report of Craig W. Lindsley, Ph.D., Regarding U.S. Patent Nos. 8,039,627 and 8,357,697 on Invalidity; and (2) Reply Expert Report of S. Craig Dyar, Ph.D., Regarding U.S. Patent Nos. 11,026,939 and 11,311,532 on Invalidity (on behalf of Lupin and Zydus) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 10/19/2023) (2)
Oct 11, 2023	255	STIPULATION TO EXTEND TIME for serving Rely Expert Reports to October 17, 2023 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David) (Entered: 10/11/2023) (2)
Oct 5, 2023	253	STIPULATION of Dismissal Without Prejudice (as to Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal Pharmatech Co., Ltd.) by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 10/5/2023 (dlw). (Entered: 10/05/2023) (2)
Oct 5, 2023	254	SO ORDERED re (23 in 1:21-cv-01067-MN, 22 in 1:21-cv-01464-MN, 15 in 1:22-cv-01124-MN, 253 in 1:21-cv-01042-MN) Stipulation of Dismissal (as to Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal PharmatechCo., Ltd.) Party Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc. terminated. Attorney Stephanie T. Coelho; Elizabeth M. Crompton; Scott A. Cunning, II; Ronald P. Golden, III; Zoe A. Goldstein; C. Kyle Musgrove; John C. Phillips, Jr; David A. Bilson and Stephen B. Brauerman terminated as to these Defendants. Signed by Judge Maryellen Noreika on 10/5/2023. (dlw) (Entered: 10/05/2023) (2)
Sep 26, 2023	252	STIPULATION TO EXTEND TIME for Plaintiff to answer, move, or otherwise respond to 251 Defendants' Amended Counterclaims to 10/5/2023 - filed by Neurocrine Biosciences, Inc. (dlw) (Entered: 09/26/2023) (2)
Sep 18, 2023	246	NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Rebuttal Expert Report of Ivan T. Hofmann; [HIGHLY CONFIDENTIAL] Rebuttal Expert Report of Anthony J. Rothschild, M.D. and [HIGHLY CONFIDENTIAL] Rebuttal Expert Report of Craig W. Lindsley, Ph.D. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 09/18/2023) (2)
Sep 18, 2023	247	NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Defendants' Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 09/18/2023) (2)
Sep 18, 2023	248	NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Rebuttal Expert Report of Pardeep Gupta, Ph.D. Regarding Noninfringement of U.S. Patent Nos. 11,026,939 and 11,311,532 and [HIGHLY CONFIDENTIAL] Zydus's Addendum to Defendants' Rebuttal Expert Report of Jonathan Steed, Ph.D. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 09/18/2023) (2)
Sep 18, 2023	249	NOTICE OF SERVICE of Defendants Sandoz Inc, Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal Pharmatech Co., Ltd.s Rebuttal Expert Report of David J. Greenblatt, M.D.; Addendum A to Defendants Rebuttal Expert Report of Jonathan Steed, Ph.D. (Sandozs ANDA Products); Rebuttal Expert Report of Dr. Maureen Donovan Regarding Noninfringement of U.S. Patent Nos. 11,026,939 and 11,311,532; Rebuttal Expert Report of Irene Richard, M.D. filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 09/18/2023) (3)
Sep 18, 2023	250	NOTICE OF SERVICE of Rebuttal Expert Report of Alan F. Parr, Ph.D., Regarding U.S. Patent Nos. 11,026,939 and 11,311,532 on Non-Infringement on Behalf of Lupin filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 09/18/2023) (2)
Sep 5, 2023	251	[SEALED] Amended ANSWER, Affirmative Defenses and COUNTERCLAIM of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal Pharmatech Co., Ltd. to Complaint for Patent Infringement (filed in C.A. No. 22-1124) by Crystal Pharmatech Co., Ltd., Crystal Pharmaceutical (Suzhou) Co., Ltd., Sandoz Inc. (Attachments: # 1 Exhibit A - Q)(dlw) (Entered: 09/26/2023) (0)
Aug 28, 2023	245	STIPULATION TO EXTEND TIME various deadlines to various dates listed - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Phillips, John) (Entered: 08/28/2023) (3)
Aug 1, 2023	244	NOTICE OF SERVICE of Opening Expert Reports of (1) Dr. Craig W. Lindsley Regarding U.S. Patent Nos. 8,039,627 and 8,357,697 on Invalidity; (2) Dr. S. Craig Dyar Regarding U.S. Patent Nos. 11,026,939 and 11,311,532 on Invalidity on Behalf of Zydus and Lupin; (3) Dr. Anthony J. Rothschild on Invalidity; (4) Dr. David J. Greenblatt Regarding U.S. Patent Nos. 10,857,137, 11,040,029, 10,952,997, 10,940,141, and 10,993,941 on Invalidity; and (5) Dr. William C. Schinzer Regarding U.S. Patent Nos. 10,065,952, 10,844,058, and 10,851,103 on Invalidity on Behalf of Zydus and Lupin filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 08/01/2023) (2)
Jul 31, 2023	241	NOTICE OF SERVICE of (i) Expert Report of John C. Jarosz (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.), (ii) Expert Report of Stephen R. Byrn, Ph.D. (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.), (iii) Expert Report of John J. Koleng, Jr., Ph.D. (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.), (iv) Expert Report of Stuart H. Isaacson, M.D., F.A.A.N. (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.), (v) Expert Report of Simon Ward, Ph.D. (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.), and (vi) Expert Report of Christoph U. Correll, M.D. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 07/31/2023) (3)
Jul 31, 2023	242	NOTICE OF SERVICE of (i) Expert Report of John C. Jarosz (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.), (ii) Expert Report of Stephen R. Byrn, Ph.D. (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.), (iii) Expert Report of John J. Koleng, Jr., Ph.D. (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.), (iv) Expert Report of Stuart H. Isaacson, M.D., F.A.A.N. (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.), (v) Expert Report of Simon Ward, Ph.D. (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.), and (vi) Expert Report of Christoph U. Correll, M.D. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 07/31/2023) (2)
Jul 31, 2023	243	NOTICE OF SERVICE of (i) Expert Report of John C. Jarosz (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), (ii) Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), (iii) Expert Report of John J. Koleng, Jr., Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), (iv) Expert Report of Stuart H. Isaacson, M.D., F.A.A.N. (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), (v) Expert Report of Simon Ward, Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), and (vi) Expert Report of Christoph U. Correll, M.D. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 07/31/2023) (2)
Jul 21, 2023	240	STIPULATION Seeking to Extend the Deadline for Service of Opening Expert Reports, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 07/21/2023) (2)
Jul 10, 2023	238	SO ORDERED re 237 Joint STIPULATION TO EXTEND TIME Regarding Expert Report Deadlines (Set/Reset Scheduling Order Deadlines - Opening Expert Reports due by 7/25/2023. Rebuttal Expert Reports due by 9/6/2023. Reply Expert Reports due by 10/3/2023). Signed by Judge Maryellen Noreika on 7/10/2023. (dlw) (Entered: 07/10/2023) (3)
Jul 10, 2023	239	NOTICE OF SERVICE of Defendants' Identification of Narrowed Prior Art References and Prior Art Combinations filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 07/10/2023) (2)
Jul 7, 2023	236	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limiteds [HIGHLY CONFIDENTIAL] Final Noninfringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 and Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limiteds Final Invalidity Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Phillips, John) (Entered: 07/07/2023) (2)
Jul 7, 2023	237	Joint STIPULATION TO EXTEND TIME Regarding Expert Report Deadlines to - filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) (Entered: 07/07/2023) (3)
Jun 30, 2023	235	NOTICE OF SERVICE of Plaintiff's Identification of Asserted Claims and Plaintiff's Infringement Contentions for U.S. Patent Nos. 8,039,627 and 8,357,697 (Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 06/30/2023) (2)
Jun 29, 2023	234	REDACTED VERSION of 229 MOTION for Teleconference to Resolve Defendant Sandoz, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal Pharmatech Co., Ltd.'s Motion for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims by Sandoz Inc.. (Golden, Ronald) (Entered: 06/29/2023) (4)
Jun 27, 2023	232	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 06/27/2023) (2)
Jun 27, 2023	233	NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) to Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 06/27/2023) (2)
Jun 26, 2023	231	Unopposed MOTION to Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Proposed Order)(Phillips, John) (Entered: 06/26/2023) (Main Document) (2)
Jun 26, 2023	231	Unopposed MOTION to Change Name of Defendant Cadila Healthcare Limited to Zydus Lifesciences Limited - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Proposed Order)(Phillips, John) (Entered: 06/26/2023) (Proposed Order) (1)
Jun 23, 2023	230	ORAL ORDER: The Court has reviewed the Motion for Teleconference to Resolve Discovery Dispute (D.I. 229). A discovery dispute teleconference is scheduled for August 3, 2023 at 1:00 PM Eastern Time before Judge Laura D. Hatcher. By no later than July 20, 2023, the party seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than July 27, 2023, any party opposing the application for relief may file a letter, not to exceed 3 pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to promptly provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: keith_kincaid@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event cancel the conference. ORDERED by Judge Laura D. Hatcher on 6/23/23. (kjk) (Entered: 06/23/2023) (0)
Jun 22, 2023	229	[SEALED] MOTION for Teleconference to Resolve Defendant Sandoz, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd., and Crystal Pharmatech Co., Ltd.'s Motion for Leave to File Amended Answer, Affirmative Defenses, and Counterclaims - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certificate of Service)(Golden, Ronald) (Entered: 06/22/2023) (0)
Jun 21, 2023	228	STIPULATION Seeking to Extend Time to Complete Fact Depositions, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 06/21/2023) (2)
Jun 20, 2023	227	NOTICE requesting Clerk to remove Tyler B. Latcham as co-counsel. Reason for request: no longer with firm. (Mayo, Andrew) (Entered: 06/20/2023) (1)
Jun 16, 2023	224	NOTICE OF SERVICE of Plaintiff's Identification of Asserted Claims (Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 06/16/2023) (2)
Jun 16, 2023	225	NOTICE OF SERVICE of Plaintiff's Identification of Asserted Claims (Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin, Inc. and Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 06/16/2023) (2)
Jun 16, 2023	226	NOTICE OF SERVICE of Plaintiff's Identification of Asserted Claims (Crystal Pharmaceutical (Suzhou) Co. Ltd., Crystal Pharmatech Co., Ltd. and Sandoz, Inc.) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 06/16/2023) (2)
Jun 12, 2023	223	ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers to request a teleconference date for Sandoz's anticipated Motion to Amend, IT IS HEREBY ORDERED that this anticipated motion is referred to Magistrate Judge Hatcher. The parties are directed to file Magistrate Judge Hatcher's "Motion for Teleconference to Resolve Discovery/Protective Order Disputes" which can be found at https://www.ded.uscourts.gov/judge/magistrate-judge-laura-d-hatcher, forms. ORDERED by Judge Maryellen Noreika on 6/12/2023. (dlw) (Entered: 06/12/2023) (0)
May 25, 2023	222	NOTICE OF SERVICE of Plaintiff's and Non-Party Joseph-Stephen DaRe's Objections and Response to Subpoena filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/25/2023) (3)
May 24, 2023	220	NOTICE to Take Deposition of Jason Gensburger filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 05/24/2023) (2)
May 24, 2023	221	NOTICE to Take Deposition of Yongqiang Li, Ph.D. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 05/24/2023) (2)
May 11, 2023	216	STIPULATION regarding Agreed Claim Construction by Sandoz Inc.. (Golden, Ronald) (Entered: 05/11/2023) (10)
May 11, 2023	217	SO ORDERED re 216 Stipulation and Claim Construction Order. Claim Construction deadlines TERMINATED. Signed by Judge Maryellen Noreika on 5/11/2023. (dlw) (Entered: 05/11/2023) (9)
May 11, 2023	218	NOTICE OF SERVICE of Defendants Sandoz Inc.'s Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Interrogatories (Nos. 1-3) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 05/11/2023) (3)
May 11, 2023	219	MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 05/11/2023) (3)
May 9, 2023	215	REDACTED VERSION of 162 Letter by Neurocrine Biosciences, Inc.. (Attachments: # 1 Attachment 1)(Mayo, Andrew) (Entered: 05/09/2023) (Main Document) (4)
May 9, 2023	215	REDACTED VERSION of 162 Letter by Neurocrine Biosciences, Inc.. (Attachments: # 1 Attachment 1)(Mayo, Andrew) (Entered: 05/09/2023) (Attachment 1) (22)
May 8, 2023	214	ORAL ORDER re 162 SEALED Letter - The redacted version of this sealed letter having not been filed in the time prescribed and a stipulation extending time to file the redacted version having not been filed, IT IS HEREBY ORDERED that the redacted version of D.I. 162 shall be filed by 5:00 PM TOMORROW or it will be unsealed on the docket. ORDERED by Judge Maryellen Noreika on 5/8/2023. (dlw) (Entered: 05/08/2023) (0)
May 5, 2023	207	NOTICE to Take Deposition of Sian Godwin (Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc.) on a time and place to be agreed upon by the parties - filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/05/2023) (2)
May 5, 2023	208	NOTICE to Take Deposition of Vaibhav Vaishnav (Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc.) on a time and place to be agreed upon by the parties - filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/05/2023) (2)
May 5, 2023	209	NOTICE to Take Deposition of Radhakrishna Shivdavkar (Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.) on a time and place to be agreed upon by the parties - filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/05/2023) (2)
May 5, 2023	210	NOTICE to Take Deposition of Helen Niu (Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc.) on a time and place to be agreed upon by the parties - filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/05/2023) (2)
May 5, 2023	211	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Sandoz's First Set of Requests for Production filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 05/05/2023) (2)
May 5, 2023	212	NOTICE OF SERVICE of Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., and Sandoz Inc.'s Supplemental Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a) and Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd.'s Amended and Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-13) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 05/05/2023) (3)
May 5, 2023	213	STIPULATION to extend time to complete fact depositions by Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David) (Entered: 05/05/2023) (2)
May 4, 2023	203	NOTICE OF SERVICE of (1) Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Interrogatories (Nos. 1-9); (2) Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Neurocrine Biosciences, Inc.'s Requests for the Production of Documents and Things (Nos. 1-8); and (3) Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (Nos. 1-4) and to Authenticate (Nos. 1-2) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Main Document 203 replaced on 5/4/2023) (dlw). Modified on 5/4/2023 (dlw). (Entered: 05/04/2023) (2)
May 4, 2023	204	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd.s Objections and Responses to Neurocine Biosciences, Inc.s First Set of Requests for Admission (Nos. 1-5); Objections and Responses to Neurocrine Biosciences, Inc.s First Set of Requests for Admission (No. 1) and Authentication (Nos. 1-4); Objections and Responses to Neurocrine Biosciences, Inc.s First Set of Requests for Production; and Objections and Responses to Neurocrine Biosciences, Inc.s First Set of Interrogatories (Nos. 1-4) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 05/04/2023) (3)
May 4, 2023	205	NOTICE OF SERVICE of (1) Defendant Lupin's Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Defendant Lupin's Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 05/04/2023) (2)
May 4, 2023	206	NOTICE OF SERVICE of Defendants' Responses to Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (Nos. 1-6) and for Authentication (Nos. 1-3) to Lupin filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 05/04/2023) (2)
May 2, 2023	202	MOTION for Pro Hac Vice Appearance of Attorney J.R. McNair - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of J.R. McNair)(Golden, Ronald) (Entered: 05/02/2023) (Main Document) (4)
May 2, 2023	202	MOTION for Pro Hac Vice Appearance of Attorney J.R. McNair - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of J.R. McNair)(Golden, Ronald) (Entered: 05/02/2023) (Certification of J.R. McNair) (1)
Apr 26, 2023	200	ORAL ORDER re 199 Letter - Having been advised by the parties that they have resolved their discovery dispute, IT IS HEREBY ORDERED that today's in-person hearing is CANCELLED. ORDERED by Judge Maryellen Noreika on 4/26/2023. (dlw) (Entered: 04/26/2023) (0)
Apr 26, 2023	201	MOTION for Pro Hac Vice Appearance of Attorney Tyler B. Latcham - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 04/26/2023) (3)
Apr 25, 2023	199	Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Resolved Discovery Dispute - re 197 Oral Order,,,, Set Deadlines/Hearings,,,. (Brauerman, Stephen) (Entered: 04/25/2023) (1)
Apr 24, 2023	198	Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Discovery Dispute Conference - re 197 Oral Order,,,, Set Deadlines/Hearings,,,. (Brauerman, Stephen) (Entered: 04/24/2023) (1)
Apr 21, 2023	196	STIPULATION seeking to postpone April 21, 2023 discovery telephone conference, by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 04/21/2023) (3)
Apr 21, 2023	197	ORAL ORDER: On April 17, 2023, the Court instructed the parties to talk to each other about their disputes so that a follow-up call with the Court (set for April 21, 2023) would be more productive than the prior call. On April 21, 2023, a few hours before the set call, the parties submitted a stipulation requesting the April 21 call be delayed. After further inquiries, it became clear that, in the five days after the Court directed the parties to TALK, they did not do so. The Court intended to address that during the April 21 call, but no counsel appeared for the call (notwithstanding that the Court had not granted the request for a delay). THEREFORE, IT IS HEREBY ORDERED that, should the parties not inform the Court that they have resolved their dispute in full by Tuesday April 25, 2023, lead trial counsel SHALL appear in person in Courtroom 4A on April 26, 2023 at 3:00 p.m. ORDERED by Judge Maryellen Noreika on 4/21/2023. (mdb) (Entered: 04/21/2023) (0)
Apr 20, 2023	189	NOTICE OF SERVICE of Zydus's [HIGHLY CONFIDENTIAL] Noninfringement Contentions filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 04/20/2023) (2)
Apr 20, 2023	190	Official Transcript of Teleconference held on 04/17/2023 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/11/2023. Redacted Transcript Deadline set for 5/22/2023. Release of Transcript Restriction set for 7/19/2023. (dh) (Entered: 04/20/2023) (0)
Apr 20, 2023	191	NOTICE OF SERVICE of Plaintiff's Supplemental Validity Contentions (Crystal/Sandoz Defendants) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 04/20/2023) (2)
Apr 20, 2023	192	NOTICE OF SERVICE of Plaintiff's Supplemental Validity Contentions (Lupin) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 04/20/2023) (2)
Apr 20, 2023	193	NOTICE OF SERVICE of Plaintiff's Supplemental Validity Contentions (Zydus) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 04/20/2023) (2)
Apr 20, 2023	194	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd's Objections and Responses to Plaintiff's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 04/20/2023) (2)
Apr 20, 2023	195	NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 04/20/2023) (3)
Apr 19, 2023	187	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd's Final Non-Infringement Contentions with Exhibits A-T filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 04/19/2023) (2)
Apr 19, 2023	188	NOTICE OF SERVICE of Lupin's Final Non-Infringement Contentions w/Exhibit A filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 04/19/2023) (2)
Apr 17, 2023	186	NOTICE OF SERVICE of Plaintiff's Objections and Supplemental Response to Defendants' Joint Interrogatory No. 5 filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/17/2023) (3)
Apr 14, 2023	185	STIPULATION TO EXTEND TIME for Contentions and Plaintiff's Opening Claim Construction Brief to April 19, 2023 and April 20, 2023 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David) (Entered: 04/14/2023) (2)
Apr 13, 2023	184	NOTICE of Lodging by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Attachments: # 1 Exhibit A)(Bilson, David) (Entered: 04/13/2023) (Main Document) (2)
Apr 13, 2023	184	NOTICE of Lodging by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Attachments: # 1 Exhibit A)(Bilson, David) (Entered: 04/13/2023) (Exhibit A) (22)
Apr 10, 2023	178	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA), Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Plaintiff's Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 04/10/2023) (2)
Apr 10, 2023	179	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendants' Second Set of Joint Requests for Production of Documents and Things (Nos. 122-133) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/10/2023) (3)
Apr 10, 2023	180	ORAL ORDER Setting Teleconference re 162 SEALED Letter - IT IS HEREBY ORDERED that a discovery dispute teleconference is set for 4/17/2023 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 4/10/2023. (dlw) (Entered: 04/10/2023) (0)
Apr 10, 2023	181	MOTION for Pro Hac Vice Appearance of Attorney Eric J. Fues - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 04/10/2023) (3)
Apr 10, 2023	182	MOTION for Pro Hac Vice Appearance of Attorney Hannah J. Thomas - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Certification of Hannah J. Thomas)(Bilson, David) (Entered: 04/10/2023) (Main Document) (2)
Apr 10, 2023	183	NOTICE OF SERVICE of Plaintiff's Objections and Supplemental Response to Defendants' Joint Interrogatory No. 9 filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/10/2023) (3)
Apr 10, 2023	182	MOTION for Pro Hac Vice Appearance of Attorney Hannah J. Thomas - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Certification of Hannah J. Thomas)(Bilson, David) (Entered: 04/10/2023) (Certification of Hannah J. Thomas) (1)
Apr 6, 2023	177	MOTION for Pro Hac Vice Appearance of Attorney Claire Fundakowski, Stephanie Coelho, Evan Lewis, and Zoe Goldstein - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of Claire Fundakowski, # 2 Certification of Stephanie Coelho, # 3 Certification of Evan Lewis, # 4 Certification of Zoe Goldstein)(Golden, Ronald) (Entered: 04/06/2023) (Main Document) (4)
Apr 6, 2023	177	MOTION for Pro Hac Vice Appearance of Attorney Claire Fundakowski, Stephanie Coelho, Evan Lewis, and Zoe Goldstein - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of Claire Fundakowski, # 2 Certification of Stephanie Coelho, # 3 Certification of Evan Lewis, # 4 Certification of Zoe Goldstein)(Golden, Ronald) (Entered: 04/06/2023) (Certification of Claire Fundakowski) (1)
Apr 6, 2023	177	MOTION for Pro Hac Vice Appearance of Attorney Claire Fundakowski, Stephanie Coelho, Evan Lewis, and Zoe Goldstein - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of Claire Fundakowski, # 2 Certification of Stephanie Coelho, # 3 Certification of Evan Lewis, # 4 Certification of Zoe Goldstein)(Golden, Ronald) (Entered: 04/06/2023) (Certification of Stephanie Coelho) (1)
Apr 6, 2023	177	MOTION for Pro Hac Vice Appearance of Attorney Claire Fundakowski, Stephanie Coelho, Evan Lewis, and Zoe Goldstein - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of Claire Fundakowski, # 2 Certification of Stephanie Coelho, # 3 Certification of Evan Lewis, # 4 Certification of Zoe Goldstein)(Golden, Ronald) (Entered: 04/06/2023) (Certification of Evan Lewis) (1)
Apr 6, 2023	177	MOTION for Pro Hac Vice Appearance of Attorney Claire Fundakowski, Stephanie Coelho, Evan Lewis, and Zoe Goldstein - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Attachments: # 1 Certification of Claire Fundakowski, # 2 Certification of Stephanie Coelho, # 3 Certification of Evan Lewis, # 4 Certification of Zoe Goldstein)(Golden, Ronald) (Entered: 04/06/2023) (Certification of Zoe Goldstein) (1)
Apr 5, 2023	175	NOTICE to Take Deposition of Eric Benevich on April 12, 2023 at 9:00 a.m. (ET) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 04/05/2023) (3)
Apr 5, 2023	176	NOTICE OF SERVICE of Defendants' Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd.'s First Set of Requests for Production filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 04/05/2023) (2)
Apr 4, 2023	170	NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (No. 1-6) and for Authentication (Nos. 1-3) of Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin, Inc. and Lupin Atlantis Holdings S.A. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/04/2023) (2)
Apr 4, 2023	171	NOTICE OF SERVICE of (i) Neurocrine Biosciences, Inc.'s First Set of Interrogatories to Sandoz Inc. (Nos. 1-3); (ii) Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (No. 1) and Authentication (Nos. 1-4) of Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd. and Sandoz Inc.; and (iii) Neurocrine Biosciences, Inc.'s First Set of Interrogatories to Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc. (Nos. 1-4) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/04/2023) (2)
Apr 4, 2023	172	NOTICE OF SERVICE of (1) Neurocrine Biosciences, Inc.'s Requests for the Production of Documents and Things to Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd. (Nos. 1-4); (2) Neurocrine Biosciences, Inc.'s First Set of Requests for Admission to Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd. (Nos. 1-5); (3) Neurocrine Biosciences, Inc.'s First Set of Interrogatories to Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc. (Nos. 1-4); and (4) Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (No. 1) and Authentication (Nos. 1-4) of Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd. and Sandoz Inc. filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/04/2023) (2)
Apr 4, 2023	173	NOTICE OF SERVICE of (1) Neurocrine Biosciences, Inc.'s First Set of Requests for Admission (Nos. 1-4) and to Authenticate (Nos. 1-2) to Zydus Pharmaceuticals (USA), Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited); (2) Neurocrine Biosciences, Inc.'s Requests for the Production of Documents and Things to Zydus Pharmaceuticals (USA), Inc., Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited) (Nos. 1-8); and (3) Neurocrine Biosciences, Inc.'s First Set of Interrogatories to Zydus Pharmaceuticals (USA), Inc., Zydus Pharmaceuticals (USA), Inc. and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited) (Nos. 1-9) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/04/2023) (2)
Apr 4, 2023	174	NOTICE OF SERVICE of Lupin's Objections and Responses to Plaintiff's Notice of Deposition to Lupin Under Fed. R. Civ. P. 30(b)(6) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 04/04/2023) (2)
Apr 3, 2023	168	NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Second Set of Joint Interrogatories (Nos. 11-15) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 04/03/2023) (3)
Apr 3, 2023	169	STIPULATION Seeking to Extend Disclosure Deadline, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 04/03/2023) (3)
Mar 29, 2023	166	PROPOSED CONSENT JUDGMENT AND INJUNCTION (Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.) by Neurocrine Biosciences, Inc. (Mayo, Andrew) Modified on 3/29/2023 (dlw). (Entered: 03/29/2023) (2)
Mar 29, 2023	167	SO ORDERED re 166 STIPULATED CONSENT JUDGMENT AND INJUNCTION. Party Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd terminated. Attorney Karen Elizabeth Keller; Brian J. Prew; Jonathan R Wise; Scott J. Bornstein and Nathan Roger Hoeschen terminated as to the Teva defendants. Signed by Judge Maryellen Noreika on 3/29/2023. (dlw) (Entered: 03/29/2023) (2)
Mar 28, 2023	165	JOINT CLAIM Construction Chart by Neurocrine Biosciences, Inc. (Mayo, Andrew) Modified on 3/29/2023 (dlw). (Entered: 03/28/2023) (19)
Mar 24, 2023	163	NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. C. P. 30(b)(6) (Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)), Notice of Deposition of Defendant Pursuant to Fed. R. C. P. 30(b)(6) (Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. and Sandoz Inc.), and Notice of Deposition of Defendant Pursuant to Fed. R. C. P. 30(b)(6) (Lupin Limited, Lupin Pharmaceuticals, Inc, Lupin Inc., Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 03/24/2023) (3)
Mar 24, 2023	164	NOTICE OF SERVICE of Identification of Narrowed Prior Art References for Use in Obviousness Combinations filed by Sandoz Inc..(Golden, Ronald) (Entered: 03/24/2023) (3)
Mar 22, 2023	161	NOTICE to Take Deposition of M.E. Kannan on a time and place to be agreed upon by the parties, filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 03/22/2023) (2)
Mar 22, 2023	162	[SEALED] Letter to the Honorable Maryellen Noreika from Stephen B. Brauerman regarding discovery dispute - re 154 Oral Order,,. (Attachments: # 1 Attachment 1, # 2 Certificate of Service)(Golden, Ronald) (Entered: 03/22/2023) (0)
Mar 21, 2023	159	STIPULATION TO EXTEND TIME for the parties to file their response to the Court's March 15, 2023 Oral Order (D.I. 154) to March 22, 2023 - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 03/21/2023) (2)
Mar 21, 2023	160	NOTICE to Take Deposition of Kristine Kim on dates and times convenient to the parties filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 03/21/2023) (3)
Mar 20, 2023	158	[SEALED] SO ORDERED re 157 Stipulation and Order to Stay (between Plaintiff and Teva Defendants). Signed by Judge Maryellen Noreika on 3/20/2023. This order has been emailed to local counsel. (dlw) (Entered: 03/20/2023) (0)
Mar 17, 2023	156	NOTICE OF SERVICE of Defendants' Joint Final Invalidity Contentions filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 03/17/2023) (2)
Mar 17, 2023	157	[SEALED] STIPULATION Seeking a Stay With Respect to the Teva Defendants Only, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 03/17/2023) (0)
Mar 15, 2023	154	ORAL ORDER - The parties have requested a discovery dispute teleconference regarding Defendants' request for discovery into the search methods Plaintiff used to find responsive documents. IT IS HEREBY ORDERED that the parties shall meet and confer again. Thereafter, on or before 5:00 PM on 3/20/2023, the parties shall provide the Court with the current version of the discovery requests, explaining what part or parts remain in dispute. The Court will not act as a negotiator to whittle down overly broad requests. Therefore, Defendants should propose requests of appropriate scope with the understanding that the Court may simply deny requests that are overly broad on their face. ORDERED by Judge Maryellen Noreika on 3/15/2023. (dlw) (Entered: 03/15/2023) (0)
Mar 15, 2023	155	NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' Joint Notice of Rule 30(b)(6) Deposition filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 03/15/2023) (3)
Mar 14, 2023	153	STIPULATION Seeking to Extend Certain Deadlines, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 03/14/2023) (3)
Mar 10, 2023	152	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd, and Crystal Pharmatech Co., Ltd.s Supplemental Initial Non-Infringement Contentions for U.S. Patent Nos. 10,065,952; 10,844,058; 10,851,103; and 10,851,104 filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 03/10/2023) (2)
Mar 7, 2023	150	NOTICE OF SERVICE of Plaintiff's Objections and Supplemental Responses to Defendants' Joint Interrogatory Nos. 2, 4, 6-7, 10 filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 03/07/2023) (3)
Mar 7, 2023	151	NOTICE OF SERVICE of Defendants' Second Set of Joint Requests for Production of Documents and Things (Nos. 122-133) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 03/07/2023) (2)
Mar 3, 2023	149	NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories (Nos. 11-15) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 03/03/2023) (2)
Feb 24, 2023	148	Defendants' Joint NOTICE to Take Deposition of Plaintiff Pursuant to Rule 30(b)(6) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Phillips, John) Modified on 2/27/2023 (dlw). (Entered: 02/24/2023) (14)
Feb 21, 2023	146	STIPULATION Regarding Case-Narrowing, Pursuant to the Court's February 15, 2023 Oral Order (D.I. 145), by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 02/21/2023) (3)
Feb 21, 2023	147	SO ORDERED re 146 Stipulation and Order regarding case narrowing. Signed by Judge Maryellen Noreika on 2/21/2023. (dlw) (Entered: 02/21/2023) (3)
Feb 15, 2023	144	Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding the Parties' Joint Submission Concerning Case-Narrowing. (Balick, Steven) (Entered: 02/15/2023) (3)
Feb 15, 2023	145	ORAL ORDER re 144 Letter - Having reviewed the parties' letter, IT IS HEREBY ORDERED that the parties shall file a stipulation setting forth their agreement for the Court's consideration. IT IS FURTHER ORDERED that today's 3:00 PM teleconference is CANCELLED. ORDERED by Judge Maryellen Noreika on 2/15/2023. (dlw) (Entered: 02/15/2023) (0)
Feb 14, 2023	143	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Initial Noninfringement Contentions for U.S. Patent No. 11,311,532 filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 02/14/2023) (2)
Feb 7, 2023	140	NOTICE OF SERVICE of (1) Lupin's Initial Non-Infringement Contentions w/Appendix A; and (2) the Joint Defense Group's Invalidity Contentions Claim Chart w/Exhibit T filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 02/07/2023) (2)
Feb 7, 2023	141	Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Defendants' Joint Answering Letter Concerning Narrowing Dispute (D.I. 135) - re 135 Order Setting Teleconference,,. (Brauerman, Stephen) (Entered: 02/07/2023) (5)
Feb 7, 2023	142	Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding Neurocrine's Answering Letter Concerning Streamlining of Issues for Trial. (Attachments: # 1 Exhibit D-E)(Balick, Steven) (Entered: 02/07/2023) (Main Document) (3)
Feb 7, 2023	142	Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding Neurocrine's Answering Letter Concerning Streamlining of Issues for Trial. (Attachments: # 1 Exhibit D-E)(Balick, Steven) (Entered: 02/07/2023) (Exhibit D-E) (16)
Feb 6, 2023	137	NOTICE OF SERVICE of Defendants Sandoz Inc. and Crystal's Initial Non-Infringement Contentions for the '532, '627, and '697 Patents and Invalidity Contentions for the '627 & '697 Patents filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 02/06/2023) (2)
Feb 6, 2023	138	Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding the Parties' Dispute Concerning Streamlining of Issues for Trial. (Attachments: # 1 Exhibit A-C)(Balick, Steven) (Entered: 02/06/2023) (Main Document) (3)
Feb 6, 2023	139	Joint Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Response to The Court's Order Setting Dispute Telephone Conference (D.I. 135) - re 135 Order Setting Teleconference,,. (Attachments: # 1 Attachment A)(Golden, Ronald) (Entered: 02/06/2023) (Main Document) (5)
Feb 6, 2023	139	Joint Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Response to The Court's Order Setting Dispute Telephone Conference (D.I. 135) - re 135 Order Setting Teleconference,,. (Attachments: # 1 Attachment A)(Golden, Ronald) (Entered: 02/06/2023) (Attachment A) (1)
Feb 6, 2023	138	Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding the Parties' Dispute Concerning Streamlining of Issues for Trial. (Attachments: # 1 Exhibit A-C)(Balick, Steven) (Entered: 02/06/2023) (Exhibit A-C) (16)
Feb 2, 2023	136	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd's Objections and Responses to Plaintiff's First Set of Interrogatories (Nos. 1-13) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 02/02/2023) (2)
Jan 31, 2023	135	ORAL ORDER Setting Teleconference re 134 Letter - Having reviewed the parties' letter, IT IS HEREBY ORDERED that a dispute telephone conference is set for 2/10/2023 at 10:00 AM before Judge Maryellen Noreika. The concurrent opening letters (of no more than three (3) pages) are due no later than 2/6/2023 and the concurrent answering letters (of no more than three (3) pages) are due no later than 2/7/2023. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 1/31/2023. (dlw) (Entered: 01/31/2023) (0)
Jan 27, 2023	134	Joint Letter to The Honorable Maryellen Noreika from Stephen B. Brauerman regarding Dispute. (Brauerman, Stephen) (Entered: 01/27/2023) (1)
Jan 23, 2023	133	SO ORDERED re 132 Stipulation and Order to Extend Time (Set/Reset Scheduling Order Deadlines: Amended Pleadings due by 3/10/2023. Fact Discovery completed by 5/5/2023. Joinder of Parties due by 3/10/2023. Claim Construction Opening Brief served by 4/17/2023. Claim Construction Answering Brief served by 5/10/2023. Claim Construction Reply Brief served by 5/19/2023). SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS. Signed by Judge Maryellen Noreika on 1/23/2023. (dlw) (Entered: 01/23/2023) (4)
Jan 20, 2023	131	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Common Requests for Admission to Defendants (Nos. 1-21) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 01/20/2023) (2)
Jan 20, 2023	132	STIPULATION and Order to Extend Time by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc.. (Golden, Ronald) (Main Document 132 replaced on 1/23/2023) (dlw). (Entered: 01/20/2023) (4)
Jan 19, 2023	127	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc.; Corporate Parent Nanomi B.V. for Lupin Inc. filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc.. (Lennon, James) (Entered: 01/19/2023) (2)
Jan 19, 2023	128	NOTICE OF SERVICE of Teva's Objections and Responses to Plaintiff's First Set of Requests for Admission (Nos. 1 - 20) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 01/19/2023) (2)
Jan 19, 2023	129	NOTICE OF SERVICE of Defendants Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., and Crystal Pharmatech Co., Ltd.'s Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Common Requests for Admission to Defendants and this Notice of Service filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd., Sandoz Inc..(Golden, Ronald) (Entered: 01/19/2023) (2)
Jan 19, 2023	130	NOTICE OF SERVICE of Responses to Neurocrine Biosciences, Inc.'s First Set of Common Requests for Admission to Defendants (Nos. 1-21) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 01/19/2023) (2)
Jan 12, 2023	124	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-13) and Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Second Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 01/12/2023) (2)
Jan 12, 2023	125	NOTICE OF SERVICE of Teva's Objections and Responses to Plaintiff's First Set of Common Interrogatories Nos. 1-13 filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 01/12/2023) (2)
Jan 12, 2023	126	NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiff's First Set of Common Interrogatories (Nos. 1-13) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 01/12/2023) (2)
Jan 11, 2023	120	NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions for U.S. Patent No. 11,311,532 (Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 01/11/2023) (2)
Jan 11, 2023	121	NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions for U.S. Patent No. 11,311,532 (Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 01/11/2023) (2)
Jan 11, 2023	122	NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions for U.S. Patent Nos. 8,039,627, 8,357,697 and 11,311,532 (Crystal Pharmaceutical (Suzhou) Co. Ltd., Crystal Pharmatech Co., Ltd. and Sandoz, Inc.) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 01/11/2023) (2)
Jan 11, 2023	123	NOTICE OF SERVICE of Plaintiff's First Supplemental Infringement Contentions and Initial Infringement Contentions for U.S. Patent No. 11,311,532 (Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited (f/k/a Cadila Healthcare Limited)) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 01/11/2023) (2)
Jan 9, 2023	119	ORAL ORDER Setting Teleconference - IT IS HEREBY ORDERED that a Telephone Conference is set for TODAY 1/9/2023 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 1/9/2023. (dlw) (Entered: 01/09/2023) (0)
Jan 6, 2023	118	Joint STIPULATION and [Proposed] Order to Extend Various Deadlines by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 01/06/2023) (4)
Dec 21, 2022	97	NOTICE to Take Deposition of Vikas Chavda on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	98	NOTICE to Take Deposition of Dr. Sachin Gahoi on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	99	NOTICE to Take Deposition of G. Kesavan on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	100	NOTICE to Take Deposition of Elizabeth Purcell on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	101	NOTICE to Take Deposition of Bhupendrasinh Vaghela on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	102	NOTICE to Take Deposition of Haowei Zhang on a time and place to be agreed upon by the parties filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	103	NOTICE to Take Deposition of Jian Yang on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	104	NOTICE to Take Deposition of Greg Seitz on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	105	NOTICE to Take Deposition of Srk Raju Sagiraju on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	106	NOTICE to Take Deposition of Rohit Mudga on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	107	NOTICE to Take Deposition of Pramod Dahibhate on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	108	NOTICE to Take Deposition of Sanjeev Gubbi on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	109	NOTICE to Take Deposition of Raveendra Nagella on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	110	NOTICE to Take Deposition of Girij Pal Singh on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	111	NOTICE to Take Deposition of Mahendra Barot on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	112	NOTICE to Take Deposition of Makrand Avachat on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	113	NOTICE to Take Deposition of Pawan Chaware on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	114	NOTICE to Take Deposition of John Derstine on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	115	NOTICE to Take Deposition of Hemant Mamania on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	116	NOTICE to Take Deposition of Ashutosh Rout on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 21, 2022	117	NOTICE to Take Deposition of Atul Kaushik on a time and place to be agreed upon by the parties. filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/21/2022) (2)
Dec 20, 2022	96	NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Common Requests for Admission to Defendants (Nos. 1-21) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 12/20/2022) (3)
Dec 13, 2022	94	ANSWER to Complaint // Plaintiff's Answer to Sandoz Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.'s Counterclaims by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 12/14/2022 (dlw). (Entered: 12/13/2022) (6)
Dec 13, 2022	95	NOTICE OF SERVICE of Neurocrine Biosciences Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-13) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 12/13/2022) (3)
Dec 6, 2022	90	ANSWER to Complaint and Affirmative Defenses by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) Modified on 12/6/2022 (dlw). (Entered: 12/06/2022) (20)
Dec 6, 2022	91	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 12/06/2022) (2)
Dec 6, 2022	92	Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Worldwide DMCC filed by Zydus Worldwide DMCC. (Bilson, David) (Entered: 12/06/2022) (2)
Dec 6, 2022	93	Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Limited. (Bilson, David) (Entered: 12/06/2022) (2)
Dec 2, 2022	88	NOTICE OF SERVICE of Defendants' Proposed Terms for Claim Construction filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd..(Golden, Ronald) (Entered: 12/02/2022) (3)
Dec 2, 2022	89	NOTICE OF SERVICE of Plaintiffs' Disclosure Regarding Claim Terms Needing Construction and Proposed Constructions filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 12/02/2022) (3)
Nov 28, 2022	87	NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-10) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 11/28/2022) (3)
Nov 22, 2022	84	MOTION for Pro Hac Vice Appearance of Attorney C. Collette Corser - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew) (Entered: 11/22/2022) (3)
Nov 22, 2022	85	Defendants' NOTICE OF DEPOSITIONS Pursuant to Fed. R. Civ. P. 30(b)(1) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) Modified on 11/22/2022 (dlw). (Entered: 11/22/2022) (4)
Nov 22, 2022	86	Plaintiff's Answer to the Counterclaim Filed by Teva, Prior to Consolidation, in C.A. No. 22-965-MN at D.I. 14 by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 11/22/2022 (dlw). (Entered: 11/22/2022) (6)
Nov 21, 2022	83	NOTICE OF SERVICE of Defendants Sandoz, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.'s Objections and Responses to Nuerocrine Biosciences, Inc.'s First Set of Requests to Defendants for The Production of Documents and Things (Nos. 1-14) filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd..(Golden, Ronald) (Entered: 11/21/2022) (2)
Nov 17, 2022	82	STIPULATION TO EXTEND TIME re parties exchange list of terms and proposed constructions to December 2, 2022 - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd.. (Golden, Ronald) (Entered: 11/17/2022) (2)
Nov 15, 2022	81	NOTICE OF SERVICE of Lupin's Objections and Responses to the First Set of Requests for Production (Nos. 1-41) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James) Modified on 11/15/2022 (dlw). (Entered: 11/15/2022) (2)
Nov 14, 2022	78	MOTION for Pro Hac Vice Appearance of Attorney Benjamin David Witte - filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 11/14/2022) (4)
Nov 14, 2022	79	NOTICE OF SERVICE of Defendants' Objections and Responses to Plaintiff Neurocrine Biosciences, Inc.'s First Set of Request for the Production of Documents and Things (Nos. 1-41) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 11/14/2022) (2)
Nov 14, 2022	80	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Zydus Lifesciences Limited's Objections and Responses to Neurocrine Biosciences, Inc.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-41) filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 11/14/2022) (2)
Nov 11, 2022	76	NOTICE OF SERVICE of Defendants Sandoz, Inc., Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.'s First Set of Initial Noninfringement Contentions filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd..(Golden, Ronald) (Entered: 11/11/2022) (2)
Nov 11, 2022	77	STIPULATION and [Proposed] Order to Extend Time (Neurocrine & Zydus) by Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Phillips, John) Modified on 11/14/2022 (dlw). (Entered: 11/11/2022) (2)
Nov 10, 2022	71	MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Certification of David M. Knapp)(Bilson, David) (Entered: 11/10/2022) (Main Document) (2)
Nov 10, 2022	72	NOTICE OF SERVICE of Lupin's Initial Non-Infringement Contentions filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James) (Entered: 11/10/2022) (2)
Nov 10, 2022	73	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s, Zydus Worldwide DMCC's and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Initial Noninfringement Contentions filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 11/10/2022) (2)
Nov 10, 2022	74	STIPULATION Seeking to Extend the Deadline by Which the Parties in the Non-Consolidated Cases Must Inform the Court Whether they Agree to be Consolidated With, and Adopt the Schedule of the Lead Case, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 11/10/2022) (5)
Nov 10, 2022	75	NOTICE OF SERVICE of Teva's Initial Non-Infringement Contentions filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 11/10/2022) (2)
Nov 10, 2022	71	MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # 1 Certification of David M. Knapp)(Bilson, David) (Entered: 11/10/2022) (Certification of David M. Knapp) (1)
Nov 9, 2022	70	NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendants' First Set of Joint Requests for Production of Documents and Things (Nos. 1-121) filed by Neurocrine Biosciences, Inc..(Balick, Steven) (Entered: 11/09/2022) (3)
Nov 4, 2022	69	Official Transcript of Teleconference held on 11/03/2022 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/28/2022. Redacted Transcript Deadline set for 12/5/2022. Release of Transcript Restriction set for 2/2/2023. (dh) (Entered: 11/04/2022) (0)
Nov 3, 2022	68	NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s, Zydus Worldwide DMCC's and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Amended Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures and Zydus Pharmaceuticals (USA) Inc.'s, Zydus Worldwide DMCC's and Zydus Lifesciences Limited's [HIGHLY CONFIDENTIAL] Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 11/03/2022) (2)
Oct 25, 2022	66	NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories (Nos. 1-10) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 10/25/2022) (2)
Oct 25, 2022	67	STIPULATION Seeking to Extend the Deadlines for Certain Contentions, by Neurocrine Biosciences, Inc.. (Balick, Steven) (Entered: 10/25/2022) (2)
Oct 19, 2022	65	ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 10/24/2022 teleconference is RESET for 11/3/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/19/2022. (dlw) (Entered: 10/19/2022) (0)
Oct 14, 2022	64	NOTICE OF SERVICE of Neurocrine Biosciences, Inc.'s First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-41) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew) (Entered: 10/14/2022) (4)
Oct 13, 2022	63	SO ORDERED re (7 in 1:22-cv-01124-MN) (62 in 1:21-cv-01042-MN) Stipulation as to Joinder and Dismissal of Certain Parties and Order. Signed by Judge Maryellen Noreika on 10/13/2022. (dlw) (Entered: 10/13/2022) (7)
Oct 12, 2022	62	STIPULATION as to Joinder and Dismissal of Certain Parties and [Proposed] Order by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd.. (Brauerman, Stephen) (Entered: 10/12/2022) (7)
Oct 6, 2022	61	ORAL ORDER Setting Teleconference: IT IS HEREBY ORDERED that a Telephone Conference is set for 10/24/2022 at 02:00 PM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 10/6/2022. (dlw) (Entered: 10/06/2022) (0)
Sep 30, 2022	59	NOTICE OF SERVICE of Defendants' First Set of Joint Requests for Production of Documents and Things (Nos. 1-121) filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 09/30/2022) (2)
Sep 30, 2022	60	NOTICE OF SERVICE of Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.s First Set of Interrogatories to Plaintiff, First Set of Requests for Admission to Plaintiff, and this Notice of Service filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd..(Golden, Ronald) (Entered: 09/30/2022) (3)
Sep 7, 2022	58	NOTICE OF SERVICE of Defendants' Joint Invalidity Contentions filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David) (Entered: 09/07/2022) (2)
Sep 2, 2022	57	MOTION for Pro Hac Vice Appearance of Attorney Christopher W. West - filed by Lupin Inc.. (Lennon, James) (Entered: 09/02/2022) (4)
Aug 18, 2022	56	STIPULATION TO EXTEND TIME for Defendants to serve initial invalidity contentions with references cited herein to September 7, 2022 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David) (Entered: 08/18/2022) (2)
Jul 7, 2022	52	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Lupin Limited, Lupin Pharmaceuticals, Inc, Lupin Inc. and Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Jul 7, 2022	53	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Cadila Healthcare Limited (now known as Zydus Lifesciences Limited)) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Jul 7, 2022	54	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Jul 7, 2022	55	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions (Crystal Pharmaceutical (Suzhou) Co. Ltd. and Crystal Pharmatech Co., Ltd.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Jul 5, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Emily L. Savas for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Jun 30, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [51] MOTION for Pro Hac Vice Appearance of Attorney Emily Savas filed by Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. ORDERED by Judge Maryellen Noreika on 6/30/2022. (dlw)
Jun 30, 2022	51	Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Emily Savas - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Attachments: # (1) Emily Savas Pro Hac Vice Certification)(Bilson, David)
Jun 30, 2022	51	Emily Savas Pro Hac Vice Certification (1)
Jun 29, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [50] Stipulation Extending Deadline for Plaintiff to serve its initial infringement contentions and produce its ANDA to 7/6/2022. ORDERED by Judge Maryellen Noreika on 6/29/2022. (dlw)
Jun 28, 2022	50	Stipulation (2) Docket Text: STIPULATION Seeking to Extend the Deadline by Which Plaintiff Must Serve Initial Infringement Contentions and Produce its NDA, by Neurocrine Biosciences, Inc.. (Balick, Steven)
Jun 21, 2022	49	Answer to Counterclaim (8) Docket Text: ANSWER to [44] Answer to Complaint,, Counterclaim, by Neurocrine Biosciences, Inc..(Balick, Steven)
Jun 13, 2022	48	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Jennifer M. Coronel as co-counsel. Reason for request: No longer affiliated with Locke Lord LLP. (Bilson, David)
Jun 2, 2022	46	Proposed Order (30) Docket Text: PROPOSED ORDER (Proposed Protective Order) by Neurocrine Biosciences, Inc.. (Mayo, Andrew)
Jun 2, 2022	47	Protective Order (30) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 6/2/2022. (dlw)
May 31, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [43] STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 1, 2022. ORDERED by Judge Maryellen Noreika on 5/31/2022. (dlw)
May 31, 2022	44	Answer to Complaint (30) Docket Text: ANSWER to Complaint (D.I. 1 in C.A. No. 22-092), COUNTERCLAIM against Neurocrine Biosciences, Inc. by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) Modified on 5/31/2022 (dlw).
May 31, 2022	45	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan)
May 27, 2022	43	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to June 1, 2022 - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew)
May 20, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [42] STIPULATION TO EXTEND TIME for the parties to submit proposed protective order to May 27, 2022. ORDERED by Judge Maryellen Noreika on 5/20/2022. (dlw)
May 20, 2022	42	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit proposed protective order to May 27, 2022 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David)
May 17, 2022	40	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) and Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery (Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
May 17, 2022	41	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants Crystal Pharmaceutical (Suzhou) Co., LTD. and Crystal Pharmatech Co., LTD.'s Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a) and Defendants Crystal Pharmaceutical (Suzhou) Co., LTD. and Crystal Pharmatech Co., LTD.'s Initial Disclosure Statement Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery, Including Electronically Stored Information filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd..(Golden, Ronald)
May 13, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [39] STIPULATION TO EXTEND TIME by which the parties must submit a proposed protective order to May 20, 2022 filed by Neurocrine Biosciences, Inc.. ORDERED by Judge Maryellen Noreika on 5/13/2022. (mdb)
May 13, 2022	39	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME by which the parties must submit a proposed protective order to May 20, 2022 - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew)
May 11, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [38] MOTION for Pro Hac Vice Appearance of Attorney Samantha M. Lerner, Tyree Petty-Williams, Karalena M. Guerrieri, and Maureen L. Rurka filed by Crystal Pharmatech Co., Ltd., Crystal Pharmaceutical (Suzhou) Co., Ltd. ORDERED by Judge Maryellen Noreika on 5/11/2022. (dlw)
May 11, 2022	38	Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Samantha M. Lerner, Tyree Petty-Williams, Karalena M. Guerrieri, and Maureen L. Rurka - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd.. (Attachments: # (1) Certification of Maureen L. Rurka, # (2) Certification of Karalena M. Guerrieri, # (3) Certification of Tyree Petty-Williams, # (4) Certification of Samantha M. Lerner)(Golden, Ronald)
May 11, 2022	38	Certification of Maureen L. Rurka (1)
May 11, 2022	38	Certification of Karalena M. Guerrieri (1)
May 11, 2022	38	Certification of Tyree Petty-Williams (1)
May 11, 2022	38	Certification of Samantha M. Lerner (1)
May 10, 2022	36	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s, Zydus Worldwide DMCC's and Zydus Lifesciences Limited's [CONFIDENTIAL] Federal Rule of Civil Procedure 26(a)(1) Initial Disclosures and Zydus Pharmaceuticals (USA) Inc.'s, Zydus Worldwide DMCC's and Zydus Lifesciences Limited's [CONFIDENTIAL] Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC.(Bilson, David)
May 10, 2022	37	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) and Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Neurocrine Biosciences, Inc..(Balick, Steven)
May 4, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [30] STIPULATION TO EXTEND TIME for Plaintiff and Zydus to Exchange Initial Disclosures to May 10, 2022. ORDERED by Judge Maryellen Noreika on 5/4/2022. (dlw)
May 4, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [33] STIPULATION TO EXTEND TIME for Plaintiff and Crystal to Exchange Initial Disclosures to May 17, 2022. ORDERED by Judge Maryellen Noreika on 5/4/2022. (dlw)
May 4, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [34] Joint STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to May 13, 2022. ORDERED by Judge Maryellen Noreika on 5/4/2022. (dlw)
May 4, 2022	35	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Lupin's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (2) Defendant Lupin's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc..(Lennon, James)
May 3, 2022	29	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Teva's Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery (2) Teva's Initial Disclosures filed by Teva Pharmaceuticals, Inc..(Hoeschen, Nathan)
May 3, 2022	30	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff and Zydus to Exchange Initial Disclosures to May 10, 2022 - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC. (Bilson, David)
May 3, 2022	31	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) and Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew)
May 3, 2022	32	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) and Plaintiff's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery (Defendants Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., and Teva Pharmaceuticals USA, Inc.) filed by Neurocrine Biosciences, Inc..(Mayo, Andrew)
May 3, 2022	33	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff and Crystal to Exchange Initial Disclosures to May 17, 2022 - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew)
May 3, 2022	34	Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to May 13, 2022 - filed by Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan)
May 2, 2022	28	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Production Pursuant to the Scheduling Order filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited.(Lennon, James)
Apr 29, 2022	24	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery (Defendants Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Apr 29, 2022	25	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery (Defendants Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc., and Lupin Atlantis Holdings S.A.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Apr 29, 2022	26	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery (Defendants Teva Pharmaceuticals, Inc., Teva Pharmaceuticals Development, Inc., and Teva Pharmaceuticals USA, Inc.) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Apr 29, 2022	27	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery (Defendants Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, and Cadila Healthcare Limited) filed by Neurocrine Biosciences, Inc..(Balick, Steven)
Apr 26, 2022	23	Notice of Substitution of Counsel (2) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd.: Entry of appearance of attorney Stephen B. Brauerman. Attorney John C. Phillips, Jr. and David A. Bilson of Phillips, McLaughlin & Hall, P.A., Scott A. Cunning II, Elizabeth M. Crompton, C. Kyle Musgrove of Parker, Poe, Adams & Bernstein, LLP terminated. (Brauerman, Stephen)
Apr 19, 2022	22	Scheduling Order (21) Docket Text: SCHEDULING ORDER: These matters are consolidated for all purposes and all filing shall be made in the lead action, C.A. No. 21-1042 (MN), only. Joinder of Parties due by 1/13/2023. Amended Pleadings due by 1/13/2023. Fact Discovery completed by 1/20/2023. Opening Expert Reports due by 7/17/2023. Rebuttal Expert Reports due by 8/28/2023. Reply Expert Reports due by 9/25/2023. Expert Discovery due by 11/3/2023. Claim Construction Opening Brief served by 3/23/2023. Claim Construction Answering Brief served by 4/20/2023. Claim Construction Reply Brief served by 5/10/2023. Claim Construction Surreply Brief served by 5/26/2023. Joint Claim Construction Brief filed by 6/2/2023. A Markman Hearing is set for 6/23/2023 at 11:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 12/18/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 9-day Bench Trial is set for 1/2/2024 at 08:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/19/2022. (dlw)
Apr 13, 2022	20	Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from Steven J. Balick regarding the Parties' Jointly Proposed Scheduling Order. (Balick, Steven)
Apr 13, 2022	21	Proposed Order (21) Docket Text: PROPOSED ORDER // Scheduling Order by Neurocrine Biosciences, Inc. (Balick, Steven) Modified on 4/14/2022 (dlw).
Apr 12, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (25 in 1:21-cv-01148-MN, 19 in 1:21-cv-01067-MN, 27 in 1:21-cv-01043-MN, 16 in 1:21-cv-01408-MN, 19 in 1:21-cv-01042-MN, 26 in 1:21-cv-01553-MN, 30 in 1:21-cv-01118-MN, 18 in 1:21-cv-01464-MN, 17 in 1:22-cv-00092-MN) Stipulation Extending Time to File Revised Proposed Scheduling Order to 4/13/2022. ORDERED by Judge Maryellen Noreika on 4/12/2022. (dlw)
Apr 11, 2022	19	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline for Submission of a Revised Proposed Scheduling Order, by Neurocrine Biosciences, Inc.. (Balick, Steven)
Apr 5, 2022	18	Transcript (20) Docket Text: Official Transcript of Teleconference held on 04/04/2022 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/26/2022. Redacted Transcript Deadline set for 5/6/2022. Release of Transcript Restriction set for 7/5/2022. (dh)
Apr 4, 2022	N/A	Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Scheduling Telephone Conference held on 4/4/2022. Discussion regarding the proposed schedule and disputes raised in the parties' proposal. A Markman Hearing is set for 6/23/2023, the Pretrial Conference will be set in December 2023 once the revised proposed schedule is filed, and a 9-day Bench Trial is set for 1/2/2024. The defendants are limited to three motions in limine collectively; if they wish to file more than three, they must submit a letter requesting such closer to trial. The revised proposed scheduling order is due by the end of the day on 4/11/2022. (Court Reporter Dale Hawkins.) Associated Cases: 1:21-cv-01042-MN et al.(mdb)
Mar 25, 2022	N/A	Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting Telephonic Scheduling Conference: IT IS HEREBY ORDERED that a telephonic Scheduling Conference is set for 4/4/2022 at 11:00 AM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/25/2022. (dlw)
Mar 24, 2022	16	Main Document (1) Docket Text: Letter to The Honorable Maryellen Noreika from Andrew C. Mayo regarding proposed scheduling order. (Attachments: # (1) Text of Proposed Order)(Mayo, Andrew)
Mar 24, 2022	16	Text of Proposed Order (23)
Mar 22, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jillian M. Schurr for Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Mar 21, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (19 in 1:21-cv-01148-MN, 15 in 1:21-cv-01067-MN, 21 in 1:21-cv-01043-MN, 14 in 1:21-cv-01464-MN, 26 in 1:21-cv-01118-MN, 12 in 1:21-cv-01408-MN, 15 in 1:21-cv-01042-MN, 21 in 1:21-cv-01553-MN, 8 in 1:22-cv-00092-MN) Stipulation to Extend Time to submit proposed scheduling order - IT IS HEREBY ORDERED that the deadline to submit the proposal scheduling order is extended through and including 3/24/2022. ORDERED by Judge Maryellen Noreika on 3/21/2022. (dlw)
Mar 21, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jitendra Malik for Lupin Atlantis Holdings S.A.,Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Mar 18, 2022	15	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which a Proposed Scheduling Order is Due, by Neurocrine Biosciences, Inc.. (Balick, Steven)
Mar 10, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (16 in 1:21-cv-01553-MN, 14 in 1:21-cv-01067-MN, 18 in 1:21-cv-01148-MN, 25 in 1:21-cv-01118-MN, 13 in 1:21-cv-01464-MN, 7 in 1:22-cv-00092-MN, 14 in 1:21-cv-01042-MN, 20 in 1:21-cv-01043-MN, 11 in 1:21-cv-01408-MN) Stipulation to Extend Time to submit a proposed scheduling order through and including 3/18/2022. ORDERED by Judge Maryellen Noreika on 3/10/2022. (dlw)
Mar 9, 2022	14	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which a Proposed Scheduling Order is Due, by Neurocrine Biosciences, Inc.. (Balick, Steven)
Feb 9, 2022	N/A	Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiff serves its opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/9/2022. (dlw)
Jan 7, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Lauren J. Dowty, James B. Monroe, Jeanette M. Roorda, and Erin M. Sommers for Neurocrine Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (Associated Cases: 1:21-cv-01067-MN, 1:21-cv-01042-MN, 1:21-cv-01148-MN, 1:21-cv-01043-MN, 1:21-cv-01118-MN, 1:21-cv-01408-MN, 1:21-cv-01553-MN, 1:21-cv-01464-MN)(srs)
Jan 4, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED re (12 in 1:21-cv-01067-MN, 12 in 1:21-cv-01042-MN, 12 in 1:21-cv-01148-MN, 11 in 1:21-cv-01043-MN, 9 in 1:21-cv-01118-MN, 9 in 1:21-cv-01408-MN, 7 in 1:21-cv-01553-MN, 11 in 1:21-cv-01464-MN) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Lauren J. Dowty, and Jeanette M. Roorda filed by Neurocrine Biosciences, Inc. ORDERED by Judge Maryellen Noreika on 1/4/2022. (dlw)
Jan 4, 2022	12	Motion for Leave to Appear Pro Hac Vice (11) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Erin M. Sommers, Lauren J. Dowty, and Jeanette M. Roorda - filed by Neurocrine Biosciences, Inc.. (Mayo, Andrew)
Jan 3, 2022	11	Answer to Counterclaim (20) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Neurocrine Biosciences, Inc..(Balick, Steven)
Dec 15, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 9 has been replaced on the docket at the request of counsel. The docket text of D.I. 9 and the corresponding So Ordered has also been updated to reflect Dr. Malik's formal first name. (dlw)
Dec 9, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Ph.D. and Jillian M. Schurr filed by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 12/9/2021. (mdb) Modified on 12/15/2021 (dlw).
Dec 9, 2021	9	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jitendra Malik, Ph.D. and Jillian M. Schurr - filed by Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. (Lennon, James) (Main Document 9 replaced on 12/15/2021) (dlw). Modified on 12/15/2021 (dlw).
Dec 9, 2021	10	Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Neurocrine Biosciences, Inc. by Lupin Inc., Lupin Limited, Lupin Atlantis Holdings S.A., Lupin Pharmaceuticals, Inc..(Lennon, James)
Oct 28, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED re [8] MOTION for Pro Hac Vice Appearance of Attorney Lance Soderstrom, Deepro R. Mukerjee, and Joseph M. Janusz filed by Lupin Limited. ORDERED by Judge Maryellen Noreika on 10/28/2021. (dlw)
Oct 27, 2021	8	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Lance Soderstrom, Deepro R. Mukerjee, and Joseph M. Janusz - filed by Lupin Limited. (Devlin, Timothy)
Oct 13, 2021	6	Stipulation (2) Docket Text: STIPULATION Regarding Waivers of Service and Establishment of Answer Deadlines, by Neurocrine Biosciences, Inc.. (Balick, Steven)
Oct 13, 2021	7	SO ORDERED (2) Docket Text: SO ORDERED re [6] Stipulated Order Regarding Waivers of Service and Answer Deadline (Set/Reset Answer Deadlines: Lupin Atlantis Holdings S.A. answer due 12/10/2021; Lupin Inc. answer due 12/10/2021; Lupin Limited answer due 12/10/2021; Lupin Pharmaceuticals, Inc. answer due 12/10/2021). Signed by Judge Maryellen Noreika on 10/13/2021. (dlw)
Jul 21, 2021	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. Associated Cases: 1:21-cv-01042-MN, 1:21-cv-01043-MN (rjb)
Jul 19, 2021	N/A	No Summons Issued (0) Docket Text: No Summons Issued. (myr)
Jul 16, 2021	1	Main Document (61) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Lupin Atlantis Holdings S.A., Lupin Inc., Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3659581.) - filed by Neurocrine Biosciences, Inc. (Attachments: # (1) Exhibit A-Q, # (2) Civil Cover Sheet)(myr)
Jul 16, 2021	1	Exhibit A-Q (573)
Jul 16, 2021	1	Civil Cover Sheet (2)
Jul 16, 2021	2	Magistrate Consent Forms (1) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr)
Jul 16, 2021	3	ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 4, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 10/11/2024. (myr)
Jul 16, 2021	4	Patent/Trademark Report to Commissioner (4) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (myr)
Jul 16, 2021	5	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.(myr)
Jul 16, 2021	1	Complaint* (1)

Lawsuits

Neurocrine Biosciences, Inc. v. Lupin Limited et al > Documents